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Abstract—Despite accounting for the majority of all cerebral
aneurysm cases, bifurcation aneurysms present many chal-
lenges to standard endovascular treatment techniques. This
study examines the treatment of bifurcation aneurysms
endovascularly with ﬂow-diverting stents and presents an
integrative computational modeling suite allowing for
rehearsing all aspects of the treatment. Six bifurcation
aneurysms are virtually treated with 70% porosity ﬂow-
diverters. Substantial reduction (>50%) in aneurysm inﬂow
due to device deployment is predicted in addition to reductions
in peak and average aneurysm wall shear stress to values
considered physiologically normal. The subsequent impact of
ﬂow-diverter deployment on daughter vessels that are jailed by
the device is investigated further, with a number of simulations
conducted with increased outlet pressure conditions at jailed
vessels. Increased outlet pressures at jailed daughter vessels are
found to have little effect on device-induced aneurysm inﬂow
reduction, but large variation (13–86%) is seen in the resulting
reduction in daughter vessel ﬂow rate. Finally, we propose a
potentially powerful approach for validation of such models,
by introducing an angiographic contrast model, with contrast
transport modeled both before and after virtual treatment.
Virtual angiograms and contrast residence curves are created,
which offer unique clinical relevance and the potential for
future in vivo veriﬁcation of simulated results.
Keywords—Bifurcation aneurysm, Flow-diverter, Stent,
Computational ﬂuid dynamics, Virtual deployment, Virtual
contrast.
INTRODUCTION
Over half (57.6%) of all cerebral aneurysms are
found to occur at vessel bifurcations.1 The treatment of
bifurcation aneurysms that are at risk of rupture is
considered signiﬁcantly more problematic than for
simpler sidewall cases.19 Current treatment of bifur-
cation aneurysms is dominated by coiling for narrow-
necked cases and stent-assisted coiling, where a scaf-
fold in the vessel lumen is needed to prevent coil pro-
lapse in more wide-necked geometries. Such stent-
assisted procedures are highly complex and often re-
quire ‘Y-stenting,’ whereby a stent is deployed in two
daughter vessels, and the proximal end of one stent
protrudes into the second stent, creating a single stent
lumen in the parent vessel.11
Bifurcation aneurysms, and wide-necked cases in
particular, may be amenable to treatment by ﬂow-di-
verter.3,26 Practically, treatment by ﬂow-diverter must
provide sufﬁcient resistance to ﬂow entering the an-
eurysm so as to ensure occlusion of the aneurysm
dome by thrombosis. The high aneurysm inﬂow rates
and substantial jetting often seen in bifurcation cases
render successful aneurysm occlusion more elusive
than in sidewall cases. Additionally, this ﬂow resis-
tance must be achieved without risking the complete
occlusion of the non-stented daughter vessel in the
bifurcation, which is jailed by the device. In short, the
device must simultaneously restrict and promote ﬂow
in areas of the vasculature that lie adjacent to one
another.19 This unique, and perhaps unrealistic, per-
formance requirement has resulted in signiﬁcant con-
cerns being expressed in the literature regarding the
efﬁcacy of ﬂow-diverter treatment in bifurcation
aneurysms.14,39
Animal models have suggested that the eﬀectiveness
of ﬂow-diverter treatment for inducing aneurysm
occlusion in bifurcation cases may be substantially
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reduced. One canine study reported aneurysm occlu-
sion at 3-months follow-up in only 14% of cases, al-
though any sidewall branches jailed by the ﬂow-
diverter remained fully patent at follow-up in all
cases.7 In a similar canine model, Raymond et al.
showed incomplete aneurysm occlusion at 3-months
follow-up in all experimental bifurcation aneurysms
that were implanted with a ﬂow-diverter. Reduction in
aneurysm size was seen in around half of the geome-
tries, but such a reduction was also accompanied by
daughter vessel stenosis.23
Additionally, signiﬁcant concerns of jailed vessel
occlusion have been reported for clinical cases in the
literature. A study conducted by Saatchi et al. included
46 ‘uncoilable’ aneurysms that originated at vessel
bifurcations, with successful treatment by the Pipeli-
neTM Embolization Device (PED) reported in 41
cases.26 In the ﬁve remaining cases (10.9% of the to-
tal), complete occlusion of the jailed daughter vessel
was reported, which contributed to the death of one
patient. Similar results were seen by Saleme et al. in a
retrospective analysis of 37 bifurcation aneurysms
treated by ﬂow-diverter.29 Complete aneurysm occlu-
sion at 6-months follow-up was reported in 97.3% of
cases, but new permanent neurological deﬁcit was seen
in 9.4% of patients. Jailed daughter vessel occlusion at
follow-up was seen in 32.4% of aneurysms, and visible
vessel narrowing was evident in a further 40.5% of
cases. However, the effects of vessel occlusion or nar-
rowing were only symptomatic in 13.5% of all aneur-
ysms.
It is clear that the response of bifurcation aneurysms
following treatment by ﬂow-diverter is understudied
and hard to predict. Additionally, the few studies that
do exist in the literature often suggest signiﬁcant lim-
itations. Previous studies have used animal models that
rely on surgically created aneurysms, which result in
aneurysms with a geometry and thrombosis response
that may not be representative of aneurysms that form
spontaneously in humans. Clinical studies of patients
treated with ﬂow-diverters oﬀer greater sophistication,
but the complication rate seen clinically may be biased
by the high complexity of the small number of speciﬁc
cases chosen. Often only the most ‘untreatable’ bifur-
cation aneurysms (wide-necked, uncoilable, re-
canalised etc.) are selected for treatment by ﬂow-
diverter, as a means of last resort.
Thus, computational ﬂuid dynamics (CFD) tech-
niques present a powerful tool for virtually assessing
the eﬀectiveness of ﬂow-diverter treatment on more
‘typical’ human bifurcation aneurysm geometries,
cases for which the clinical treatment by ﬂow-diverter
would currently present serious ethical concerns. In
this study, a number of patient-speciﬁc bifurcation
aneurysm geometries are virtually treated by ﬂow-di-
verter. The resulting changes in aneurysm hemody-
namic environment due to device deployment are
modeled with transient CFD simulations. The short-
comings of such a model are also interrogated. A
fundamental limitation to such simulations is the
change in outlet boundary condition of a vessel jailed
by the ﬂow-diverter device, a condition that cannot be
ascertained a priori. In this study, a parameterization
of the outlet boundary conditions is introduced, to
attempt to quantify this error. Finally, a virtual con-
trast transport model is also discussed, which may pave
the way towards in vivo veriﬁcation of CFD simula-
tions and the incorporation of realistic patient-speciﬁc
boundary conditions. This study builds on work pre-
viously discussed by the authors regarding fast
deployment algorithms and vessel jailing 22 but focuses
speciﬁcally on the clinically vital case of bifurcation
aneurysm treatment, models such treatment by ﬂow-
diverter in silico for the ﬁrst time in the literature, and
presents a pathway to future in vivo veriﬁcation.
MATERIALS AND METHODS
Aneurysm Geometries and Virtual Device Deployment
Six anatomically accurate bifurcation aneurysm
geometries are selected: three examples of a Basilar tip
aneurysm and three examples of an Internal Carotid
terminus bifurcation aneurysm. The geometries are
segmented from CTA data in OsiriX (OsiriX v.4.1.1,
Freeware) and converted to STL format before being
imported into Blender (Stichting Blender Foundation,
Amsterdam, The Netherlands). The geometries are
trimmed to result in parent and daughter vessel lengths
of around ﬁve vessel diameters distal and proximal to
the aneurysm location, as shown in Fig. 1.
The ﬂow-diverter device implanted virtually has a
‘rhomboid’ mesh design with 70% porosity, 48-strand
design, a 30 lm wire diameter, and a pore diameter of
120–260 lm.All properties are chosen to approximately
match those of commercially available ﬂow-diverter
devices: the SILK (Balt Extrusion, Montmorency,
France) and the PED (EV3/Covidien, Irvine, CA). The
device is created in a range of diameters (2.0–5.0 mm)
and lengths (15–40 mm) that are also similar to com-
mercially available devices.4 The geometry vessel
diameters both proximal and distal to the aneurysms
shown inFig. 1 aremeasured and an appropriately sized
device is chosen in accordance with current device
manufacturer’s recommendations. Across all six
geometries the ﬂow-diverter devices deployed are of
2.50–3.50 mm diameter and 20–30 mm length.
Realistic device deployment is achieved with an in-
house fast deployment algorithm that has been dis-
cussed in detail by the authors previously.22 Brieﬂy, the
PEACH et al.
virtual deployment method is underpinned by a sim-
pliﬁed stent representation whereby each strut is
approximated by its centerline with no explicit thick-
ness. Deformation of the strut is modeled by both
linear and torsional springs connecting each node, with
the stiffness of each spring related to the strut thickness
and length.30,31 Contact between the device and vessel
wall is modeled with a no-slip condition applied to the
device node when the strut makes contact with the
vessel wall. Following deployment, the thickness of
each device strut is then added back to the strut cen-
terlines by sweeping a cylindrical cross-section in
Blender, as shown in Fig. 2.
The speed of the fast deployment method comes at
the cost of a number of assumptions, most signiﬁcantly
both linear elasticity and the representation of inter-
woven wires free to slide over one another as ﬁxed and
planar struts. However, errors in deployed position
introduced by such assumptions have been shown to
be small when compared to other simulations such as
full ﬁnite element deployments2,30 as well as in vitro16
and in vivo5 experiments.
The initial phase of the deployment process involves
crimping the device to simulate the stored elastic en-
ergy seen clinically for a ﬂow-diverter compressed in its
delivery catheter. In the clinical setting, a ﬂow-diverter
is typically deployed with a size 3 or 4 Fr delivery ca-
theter (1–1.33 mm diameter), which results in device
compression to around 33% of the original diameter
for the ﬂow-diverters virtually deployed in this study.
Once crimped to the delivery catheter diameter, the
device is virtually aligned to the parent vessel centerline
and advanced to the aneurysm neck for expansion, as
shown in Fig. 3a.
In order tomimic the gradual device unsheathing seen
clinically, the deployment process is initiated at the
distal tip of the device and gradually progresses proxi-
mally, which results in a deployment similar to that
shown in Fig. 3. Due to both the rigid vessel wall and a
small degree of device oversizing (as recommended by
the manufacturers of devices used clinically) some areas
of the device remain under-expanded. This under-ex-
pansion is identical to the localized device compression
seen in clinical practice, which is common along the in-
side edge of the device in areas of vasculature with high
curvature. In the deployment process across all six an-
eurysm geometries equilibrium is typically reached in
around 200 iterations. Importantly for clinically mean-
ingful rehearsals (often of multiple proposed deploy-
ment scenarios), this computation is very fast,
approaching real-time speeds. Following device
deployment, the mesh of the ﬂow-diverter device is
trimmed to remove extreme distal and proximal por-
tions, thereby reducing computational mesh size.
FIGURE 1. Bifurcation aneurysm geometries selected for virtual flow-diverter deployment. Major arterial segments: (A) basilar
artery (BA); (B) internal carotid artery (ICA); (C) posterior cerebral artery (PCA); (D) superior cerebellar artery (SCA); (E) anterior
cerebral artery (ACA); (F) middle cerebral artery (MCA). Geometry inlets are located at the BA or ICA respectively (parent vessels)
with all remaining arteries (the daughter vessels) corresponding to geometry outlets.
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Computational Modeling
Transient CFD computations are run for each of
the six aneurysm geometries both with and without a
ﬂow-diverter device deployed. The unsteady 3D Na-
vier–Stokes equations describing blood ﬂow in the
geometries are solved assuming incompressible New-
tonian ﬂow using the ﬁnite volume method in CFD-
ACE + (ESI Group, Paris, France). A central diﬀer-
ence scheme is used for spatial diﬀerentiation as well as
a Crank–Nicholson scheme for time marching, both of
second order accuracy. A blood density of 1000 kgm3
and a dynamic viscosity of 0.004 PaS are assumed. The
SIMPLE-Consistent (SIMPLEC) pressure correction
method and an algebraic multigrid method for con-
vergence acceleration are used.20,36,38
A heart rate of 75BPM is assumed with a time step
of 0.01 s (see discussion on mesh and time step inde-
pendence below). The periodic variation of the mean
inlet velocity of each parent vessel is scaled to ﬁt vol-
umetric ﬂow curves generated from a 1D model of the
arterial tree.24 Typical ﬂow proﬁles for the ICA and
BA parent vessels over the cardiac cycle are shown in
Fig. 4, with mean ﬂow rates over the cardiac cycle of
230 and 120 mL/min respectively. Such inlet boundary
conditions result in a range of instantaneous inlet
Reynolds numbers of 169–980 across the geometries,
conﬁrming the laminar nature of the ﬂow. A radially-
symmetric parabolic inlet velocity proﬁle is prescribed,
as the relatively small Womersley number of the inﬂow
(1.68–2.72) and relatively straight portions of vessel
upstream of the geometry inlets suggest little departure
in velocity proﬁle from a Poiseuille solution.10 Three
full cardiac cycles are simulated, with the ﬂow distri-
FIGURE 3. Virtual deployment of a flow-diverter device in the ICA_02 geometry from crimped configuration (a) to deployed
position (d).
FIGURE 2. Detail of the centerline vertex representation of
the device (blue) and circular cross-section strut thickness
added in Blender after deployment (black).
PEACH et al.
bution only measured in the third cycle in order to
remove as many transient effects of the pulsatile ﬂow
proﬁle as possible. Aneurysm inﬂow (and consequently
ﬂow reduction) is calculated at each time step through
an aneurysm inlet plane meeting the criteria detailed in
the following section.
A ﬁxed pressure boundary condition is applied to all
outlets of each geometry. It should be noted that such
a condition may be unrealistic in the long-term for
vessels that are subsequently jailed after stent deploy-
ment, when a higher back-pressure is likely due to
time-dependent stent endothelialisation and vessel
narrowing.29 In order to brieﬂy investigate the inﬂu-
ence of the outﬂow pressure boundary conditions
applied to both jailed and patent daughter vessels, a
number of additional steady state computations are
performed. These simulations are conducted at mean
parent vessel ﬂow rate and with variable outlet pres-
sure boundary conditions applied to all daughter ves-
sels jailed by the device. Only steady state
computations are performed to both represent long-
term average conditions and to allow for ﬁxed pressure
resistances to be used, eliminating the complexity of
the transient ﬂow impedance behavior seen at areas of
stenosis, discussed elsewhere in the literature.37
This simpliﬁed approach to modeling increased
resistance in the jailed vessels with increased pressure
outlet conditions is of course undermined by no access
to such resistance values and no means to easily mea-
sure or model them a priori. As such, a range of
pressure values are chosen, which are of the order of
both the pressure gradient present across the vessel
bifurcations discussed and that typically induced by a
ﬂow-diverter obscuring an aneurysm neck.15 The
validity of this simpliﬁcation may be evaluated in the
future with in vivo imaging of a jailed vessel and a
virtual contrast model similar to that discussed in the
following section.
Accordingly the outlet pressure boundary condi-
tions of the jailed vessels are increased in 100 Pa
increments to a maximum of 300 Pa (2.25 mmHg)
above the outlet pressure condition of the stented
daughter vessel. Steady state simulations are run with
the same meshes and solver parameters as previously
discussed. Both sets of transient and steady simulations
are run on 16, 2.93 GHz cores with Gigabit intercon-
nectivity and parallelisation implemented with cell-
number based domain decomposition.
Finally, in an eﬀort to visualize the aneurysm
hemodynamic environment in a more clinically fo-
cussed manner, a virtual angiographic contrast model
is implemented for one aneurysm geometry. Such a
visualization has the potential to become a powerful
tool for in vivo veriﬁcation of the predicted in silico
ﬂow regime, with the predicted rate of aneurysm con-
trast decay and daughter vessel ﬂow-distributions
being compared to clinical results.32 Contrast is mod-
eled computationally as an independent scalar quantity
FIGURE 4. Mesh independence graphs for both the BA_02 and ICA_02 geometries at salient points in the cardiac cycle and mean
flow rate. The mesh fineness level at which independence (<1% variation) is reached is indicated in the green box.
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introduced at the simulation inlet and transported in
the bulk ﬂow in a similar manner to dye particles.
Although this method is a major simpliﬁcation of what
is, in reality, a two-ﬂuid mixing problem, the reduction
in computational cost of the simpliﬁcation is consid-
erable. This simpliﬁed methodology has been used
widely in the literature for over a decade in an attempt
to correlate in vivo and in silico aneurysm ﬂow pat-
terns, but the use of the technique to virtually model
treatment by ﬂow-diverter has thus far been relatively
neglected.6,8,9,27
The transport of the scalar contrast quantity in the
vasculature is governed by the scalar transport equa-
tion (Eq. (1)).
@ðq/Þ
@t
þr  ðq/uÞ ¼ r  ðC/r/Þ þ S/ ð1Þ
where u = generic scalar quantity, Cu = the scalar-
speciﬁc diffusion coefﬁcient and Su = any scalar
source terms.
The scalar quantity does not alter the simulated
blood density or viscosity. The scalar has a diﬀusivity
in blood of 1.0 9 1027 m2/s, which is an order of
magnitude estimate based on the diffusivity of tracer
particles in blood ﬂow.25 Additionally, the dominance
of convection over diffusion in the ﬂow is likely to
render the effects of any inaccuracy in estimating the
diffusivity small.28
A uniform contrast bolus with a value of unity over
the entire cardiac cycle is applied at the geometry inlet,
with the resulting contrast residence proﬁle assumed to
represent typical contrast residence averaged over one
cardiac cycle. The contrast bolus is introduced after
two full cardiac cycles (1.60 s real time) to reduce the
inﬂuence of initial transient ﬂow eﬀects. The simula-
tion is run for a further two cardiac cycles after the
introduction of the contrast ceases, giving a total
simulation time of ﬁve cardiac cycles (4.00 s real time).
The model is implemented in the CFD-ACE + plat-
form (ESI Group, Paris, France) with all simulations
run on 32, 2.93 GHz cores and the same hardware
architecture previously detailed.
Mesh Independence
Transient ﬂow mesh independence tests are per-
formed for representative geometries from each loca-
tion (in this case, geometries BA_02 and ICA_02), with
and without a device deployed. The grid independence
test metric employed is the mean volumetric ﬂow at the
aneurysm neck. The meshing of each geometry is
completed with a Projected Single Domain con-con-
forming mesh, an Omnitree Cartesian tree type, and
three near-wall Cartesian layers to give a smooth and
well-resolved boundary deﬁnition. Meshes are gener-
ated at increasing levels of ﬁneness with minimum cell
densities in the range of 1–50,000 elements/mm3. An-
eurysm inﬂow is measured through a plane deﬁned at
the aneurysm neck. The plane must be placed as close
to the natural neck of the aneurysm without falling too
close to the device, which can lead to spurious results
from local vorticity, as observed by Kim et al.13 The
solution is assumed mesh independent when the dis-
crepancy in aneurysm inﬂow between two consecutive
meshes falls below 1%. Aneurysm inﬂow is measured
at salient points in the cardiac cycle (peak systole, di-
crotic notch etc.) as well as a mean aneurysm inﬂow
calculated over a single cardiac cycle. Three full car-
diac cycles were simulated with results measured from
the ﬁnal cycle in order to remove transient effects.
Simulations run for both representative geometries
suggest mesh independence at meshes with a typical
minimum cell density ﬁner than 4000 elements/mm3, as
shown in Fig. 4. Such mesh densities meet the
requirements discussed in the literature for smooth
velocity and WSS resolution 33,34 and are similar to the
mesh-independent values calculated for cerebral an-
eurysms both with and without devices deployed pre-
viously obtained by the authors.21,22 Additionally, at
this level, the number of mesh elements in each
geometry measurement plane exceeds the recommen-
dation of Jou et al. that is required to fully resolve ﬂow
features.12 This mesh independence analysis results in
mesh sizes that vary between 3,410,000 and 7,200,000
elements across all six geometries, both with and
without the device implanted.
Mesh independence tests were also performed at the
same mesh resolution levels but using a metric of
variation in wall shear stress (WSS). Less than 1%
variation in spatio-temporal mean and maximum an-
eurysm WSS was seen at the same mesh resolution
highlighted in Fig. 4 (>4000 elements/mm3). WSS
measurements are considerably more sensitive to local
mesh resolution (as a derivative of the velocity ﬁeld)
than inﬂow (the integral of the velocity ﬁeld), however,
aneurysm inﬂow was chosen as a metric in this study in
order to also capture the importance of mesh reﬁne-
ment at the aneurysm neck and local to the device
struts, where the magnitude of velocity gradients often
far exceed those at the aneurysm wall.
The independence of the transient ﬂow solution with
time-step size is also investigated. Simulations of the
representative geometries were run at time-steps (Dt)
of 0.05, 0.01 and 0.005 s. Results indicated that
Dt = 0.01 s oﬀered both good convergence of solution
(unlike Dt = 0.05 s) and no signiﬁcant change in pre-
dicted ﬂow pattern when compared to Dt = 0.005 s.
Such a choice of time-step is consistent with similar
CFD studies.12,17,35
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RESULTS
In the transient simulations with and without a de-
vice deployed, each time step for all aneurysm
geometries converges to ﬁve orders of magnitude in
less than 100 iterations and around 45 min for a given
time step. The aneurysm inﬂow reduction due to ﬂow-
diverter deployment is shown in Fig. 5 as both the
average over the entire cardiac cycle and the range of
instantaneous reductions observed. The percentage
aneurysm inﬂow reduction is calculated from the rel-
ative inﬂow rate reduction (inﬂow without device -
inﬂow with device) divided by the original inﬂow rate
(without device). Wall shear stress (WSS) at peak
parent vessel ﬂow rate, both with and without the ﬂow-
diverter device deployed, is shown in Fig. 6. Flow
streamlines at mean parent vessel ﬂow rate before and
after virtual treatment are shown in Fig. 7. The stented
daughter-vessel (mean) ﬂow rates, both before and
after device deployment, are summarized in Table 1.
The steady state simulations, run with parameterized
increasing jailed daughter vessel outlet pressure condi-
tions as discussed above, all converge to ﬁve orders of
magnitude in less than 2000 iterations and around 12 h
per simulation. The relative increase in device-induced
aneurysm inﬂow reduction as a result of the change in
outlet pressure condition is plotted in Fig. 8. The frac-
tion of total ﬂow exiting the daughter vessel implanted
with the device is also shown in Fig. 8, for the range of
outlet pressure conditions imposed. The corresponding
sum of ﬂows, leaving the jailed daughter vessel(s) with a
0 Pa and +300 Pa outlet pressure boundary condition,
are summarized in Table 2.
Finally, the transient simulation of the ICA_02
geometry modeling virtual contrast transport is com-
pleted, with each simulation time-step converging to
ﬁve orders of magnitude residual reduction in less than
100 iterations and in a typical solution time of 30 min
per time step. The corresponding relative contrast
concentration (mean concentration over the entire
aneurysm dome) for the geometry with and without a
ﬂow-diverter device deployed is plotted in Fig. 9. A
number of ‘virtual angiograms’ are generated by pro-
jecting the 3D contrast concentration into a 2D plane,
and are also shown in Fig. 9.
DISCUSSION
Aneurysm Inﬂow Reduction and Wall Shear Stress
The reduction in aneurysm inﬂow rate after ﬂow-di-
verter deployment is shown as both a mean over the
cardiac cycle and the range of values seen over the
cardiac cycle in Fig. 5. The larger range in ICA parent
vessel ﬂow rate compared to the BA (a range of 130–570
and 105–180 mL/min respectively) results in a greater
range of aneurysm inﬂow reduction seen over the car-
diac cycle in the ICA geometries. Despite the distinct
divide in the range of ﬂow reductions between the two
aneurysm locations, the mean ﬂow reduction seen
across all six aneurysm geometries remains relatively
constant and falls within the range of around 50–70%.
The action of the ﬂow-diverter device appears to be
to diﬀuse ﬂow entering the aneurysm dome and to
remove strong inﬂow jets. This reduction in jetting
behavior can be clearly seen in the WSS plots of the
aneurysm geometries both with and without a device
deployed, which are shown in Fig. 6. Figure 6 depicts
the WSS at peak systole, and although aneurysm WSS
magnitude is seen to vary throughout the cardiac cycle,
the broad pattern WSS distribution remains very
similar to the peak-systole distributions shown in the
ﬁgure.
Across ﬁve of the six aneurysm geometries simu-
lated (all but ICA_01) the peak values of WSS within
the aneurysm are reduced to an approximately normal
range of less than 4 Pa, after ﬂow-diverter deploy-
ment.18 Although the peak WSS remains higher than
4 Pa in the ICA_01 geometry after device deployment,
the relative reduction in WSS due to the device is still
substantial. Neither the degree of overall WSS reduc-
tion due to the device nor the persistence of localized
aneurysm WSS peaks following device deployment
appears to correlate with the aneurysm inﬂow reduc-
tion achieved by the ﬂow-diverter. For example, the
ICA_02 case shows very little change in aneurysm
WSS pattern or magnitude after treatment, with a
68.7% ﬂow reduction. By contrast, the ICA_03 case
shows complete obliteration of strong WSS peaks and
a large overall reduction in WSS following device
deployment, but a slightly lower inﬂow reduction of
53.9%. A possible explanation for this discrepancy is
FIGURE 5. Mean aneurysm inflow reduction due to device
deployment. The range in flow reduction seen over the car-
diac cycle is indicated in black.
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seen in Fig. 7, where the more dramatic changes in
WSS reduction are seen to correspond to geometries
with greater changes in aneurysm ﬂow pattern (inlet jet
location, number and locations of areas of circulation
etc.) after device deployment, such as the BA_01,
ICA_01 and ICA_03 cases.
The Eﬀect of Daughter Vessel Jailing
Table 1 shows very little change in stented daughter
vessel ﬂow rate after ﬂow-diverter deployment (<5%
in 5/6 cases and <1% in 3/6 cases). These results
suggest that the presence of the ﬂow-diverter alone (the
outlet pressure of all daughter vessels remain constant)
does not substantially alter the distribution of ﬂow to
each daughter vessel across all six aneurysm geome-
tries.
Figure 8a suggests that the relative change in mean
aneurysm inﬂow reduction after increasing the
daughter vessel outlet pressure conditions is also small;
in all cases less than an 11% increase in device-induced
inﬂow reduction is seen at the maximum outlet pres-
FIGURE 6. WSS at peak parent vessel flow rate both before and after device deployment.
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sure of +300 Pa. Even in the most extreme case of the
ICA_02 geometry, where the +300 Pa pressure con-
dition results in near complete occlusion of the jailed
vessel, comparatively little change in aneurysm inﬂow
is seen.
The overall pressure gradient (inlet–outlet) across
the six geometries after device deployment with con-
stant daughter vessel outlet pressures is in the range of
144–528 Pa. Consequently, the maximum pressure bias
(+300 Pa) applied at the jailed daughter vessels rep-
resents a relative pressure increase of 50–200% of the
overall stented geometry pressure gradient, depending
upon the aneurysm geometry. More dramatic changes
in aneurysm inﬂow reduction (Fig. 8a) are seen in
geometries where the increased daughter vessel outlet
pressure is large relative to the overall pressure gradi-
ent for the geometry. Greater increases in aneurysm
inﬂow reduction are seen in the ICA cases (7.0–
11.0%), where the maximum boundary-condition in-
crease (+300 Pa) represents 79–208% of the overall
geometry pressure gradient. Lower increases in inﬂow
reduction are seen in the BA cases (1.1–4.7%), where
the maximum boundary-condition increase represents
57–111% of the overall geometry pressure gradient.
Figure 8b shows a greater fraction of the total
outﬂow exiting through the stented daughter vessel
across all three ICA cases than for the BA geometries.
Such a pattern is most likely due to the reduced
number of daughter vessels in the ICA geometries (two
instead of the four vessels in the BA geometries), which
results in the stented vessel occupying a larger fraction
of the total outlet area in the ICA case. All three ICA
geometries show relatively similar fractions of outﬂow
in the stented vessel at each outlet pressure condition,
ranging from 68 to 73% with a 0 Pa outlet condition
and 87–96% with a +300 Pa jailed vessel outlet
FIGURE 7. Lines tangent to instantaneous velocity vectors, at mean parent vessel flow rate, for all six aneurysm geometries with
and without a device deployed. Larger variation in aneurysm flow pattern (jet location, number and location of areas of circulation
etc.) after device deployment appears to correspond to greater WSS variation, shown in Fig. 6.
TABLE 1. Stented daughter-vessel mean flow rate with and without a flow-diverter device deployed.
BA_01 BA_02 BA_03 ICA_01 ICA_02 ICA_03
No device (mL/min) 62.2 37.6 64.4 162 155 165
With device (mL/min) 63.0 35.6 64.4 166 154 166
Change (%) +1.29 25.32 0.00 +2.47 20.65 +0.60
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pressure condition. By contrast, substantial variation
in the fraction of ﬂow leaving the stented vessel is seen
in the three BA cases with the fraction ranging from 32
to 54% with a 0 Pa outlet condition and 41–77% with
a +300 Pa jailed vessel outlet pressure condition. This
greater variation seen in the BA cases is attributed to
greater localized geometric variations; more variation
is seen for the BA cases, where anatomical differences
(relative diameters, patency, and positions of daughter
vessels) are more substantial across the geometries.
Additionally, such variation also suggests that average
models of the vasculature may not be effective for
outﬂow boundary condition estimation.
From Fig. 8b, it is also clear that the fraction of
ﬂow leaving the stented daughter vessel in each
geometry appears to scale approximately linearly with
the increased outlet pressure of the jailed daughter
vessels. However, such a linear correlation must
breakdown as the increasing pressure condition of the
jailed daughter vessels moves towards directing 100%
of the ﬂow through the stented daughter vessel (com-
plete occlusion of the jailed daughter vessels). The
decrease in jailed daughter vessel outﬂow due to the
increased outlet pressure boundary conditions is sum-
marized in Table 2. From the table, it is apparent that
while aneurysm inﬂow reduction is relatively insensi-
tive to outﬂow pressure increases, substantial reduc-
tions in jailed vessel ﬂow rate are seen after applying
the +300 Pa boundary condition. Across all six
geometries, jailed daughter vessel ﬂow falls by 12.9–
86.3% with the 300 Pa pressure increase. As previously
discussed, the greatest reductions are seen for geome-
FIGURE 8. The effect of jailed daughter vessel outlet pressure conditions (+0 to 300 Pa) on aneurysm inflow reduction due to the
device (a) and stented daughter vessel outflow distributions (b).
TABLE 2. Total jailed vessel(s) outflow in each geometry with an unaltered outlet pressure (0 Pa) and the maximum increased
outlet pressure (+300 Pa).
BA_01 BA_02 BA_03 ICA_01 ICA_02 ICA_03
0 Pa (mL/min) 57.8 82.4 55.6 68.0 75.0 65.0
+300 Pa (mL/min) 29.5 71.8 41.9 33.4 10.3 24.0
Change (%) 249.0 212.9 224.6 250.9 286.3 263.1
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tries where the overall pressure gradient for the
geometry (inlet–outlet) is small compared to the
300 Pa pressure increase. The range of the pressure-
induced reduction in jailed vessel ﬂow rate seen in
Table 2 is signiﬁcant and varies from almost no change
(12.9% reduction) to near-complete ﬂow stasis
(86.3%). Such sensitivity again illustrates the highly
patient-speciﬁc nature of the ﬂow patterns seen within
the simulated vasculature and suggests that entirely
patent-speciﬁc boundary conditions may be necessary
to accurately model ﬂow-diverter treatment outcomes
in bifurcation aneurysms.
Virtual Angiography and In Vivo Veriﬁcation
Finally, the results of the two virtual contrast sim-
ulations for the ICA_02 geometry are shown in Fig. 9
as both contrast residence curves and virtual angiog-
raphy. For simplicity, these simulations are conducted
assuming equal outlet pressures for both patent and
jailed daughter vessels. The results of the ICA_02 case
serve as an illustrative example for how future studies
may begin to verify simulations with in vivo results.
Such veriﬁcation would offer particular insight into the
bifurcation aneurysm cases discussed here, where cur-
rently the lack of accurate a priori boundary conditions
for vessels jailed by a ﬂow-diverter severely limits the
applicability of any simulation results.
From Fig. 9, it is clear that device deployment
substantially alters the distribution and decay of con-
trast in the aneurysm dome. The degree of contrast
inﬁltration is markedly reduced after device deploy-
ment (compare angiographic images AND and AD in
Fig. 9), which supports the predicted reduction in both
aneurysm inﬂow rate and inﬂow jetting seen previ-
ously. The mechanism of clearing the contrast from the
aneurysm dome also appears substantially altered after
device deployment: with no device deployed, contrast
washes out of the aneurysm symmetrically with both
sides of the aneurysm dome visible throughout the
decay. After device deployment, the decay appears
more asymmetric with slow-moving ﬂow in the jailed
vessel gently carrying contrast away from the aneur-
ysm dome at a reduced rate.
The decay portions of the curves in Fig. 9 are well
described by an exponential decay curve, when ﬁtted to
relative contrast concentrations ranging from 100% to
10% of the peak concentration (coefﬁcient of deter-
mination (R2) >0.90). Around a 67% reduction in
decay rate is seen after device deployment with a ‘No
Device’ exponential decay rate of 3.86 s21 and a ‘with
device’ decay rate of 1.46 s21. It should be remem-
bered, however, that these results along with those of
the previous section are currently entirely unveriﬁed.
If in vivo angiography of the ICA_02 geometry both
before and after ﬂow-diverter treatment had been
FIGURE 9. Simulated aneurysm contrast residence curves and virtual angiography generated for the ICA_02 geometry both with
and without a flow-diverter device deployed.
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available to the authors, the contrast decay rate and
the fraction of contrast leaving each daughter vessel
could have been used to approximately verify the
simulation outlet boundary conditions imposed. This
would then allow for patient-speciﬁc boundary condi-
tions of the in vivo geometry to be estimated indirectly.
However, the computational power required for such a
study is considerable, as a number of virtual contrast
simulations would need to be implemented at varying
outlet pressure conditions. Finally, such a methodol-
ogy would only be viable for bifurcation aneurysms
treated by ﬂow-diverter alone with no coils present in
the aneurysm dome.
CONCLUSIONS
This computational study of six cerebral bifurcation
aneurysms has shown that substantial reductions in
aneurysm inﬂow (mean reduction >50%) may be
achieved with treatment by ﬂow-diverter. Flow-di-
verter deployment also reduced both peak and mean
WSS values within the aneurysm dome; in ﬁve aneur-
ysm geometries the aneurysm WSS distribution
throughout the cardiac cycle was reduced to values
considered physiologically normal (< 4 Pa). Assum-
ing no change in jailed vessel pressure boundary con-
ditions, the deployment of a ﬂow-diverter device in all
six aneurysms does not substantially alter the distri-
bution of ﬂow to the rest of the arterial tree.
Simulations conducted with increased outlet pres-
sure boundary conditions for daughter vessels jailed by
a ﬂow-diverter device showed little variation in an-
eurysm inﬂow reduction: the maximum 300 Pa
(2.25 mmHg) increase in daughter vessel outlet pres-
sure resulted in less than 11% increase in ﬂow-diverter
induced aneurysm inﬂow reduction. However, the in-
crease in jailed vessel outlet pressure does have a dra-
matic eﬀect on daughter vessel ﬂow rate: an increase of
300 Pa in outlet pressure was shown to result in a 12.9–
86.3% reduction in the total daughter vessel mean
ﬂow. Such sensitivity of ﬂow rate to outlet pressure
condition reinforces the highly patient-speciﬁc nature
the ﬂow patterns seen. However, these results are en-
tirely unveriﬁed and further development of in vivo
veriﬁcation techniques will be needed to begin to
investigate the validity of the boundary conditions
imposed in such simulations.
Finally, the modeling of angiographic contrast
transport within the aneurysm geometry, both with
and without a ﬂow-diverter device deployed, has been
discussed. Simulated contrast decay in the simulated
aneurysm is well described by an exponential decay
curve, which, in the case discussed (ICA_02), results in
a 67% reduction in contrast decay rate after ﬂow-di-
verter deployment. Finally, the incorporation of vir-
tual contrast residence models into future patient-
speciﬁc aneurysm CFD simulations and combined
with clinical angiography, may provide a viable route
to in vivo veriﬁcation of simulation boundary condi-
tions and ﬂow patterns.
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